Electromed, Inc. (ELMD) director granted 3,000 restricted shares in Form 4

Q: What did Electromed (ELMD) disclose in this Form 4 filing?

Electromed (ELMD) disclosed that one of its directors received a grant of 3,000 shares of restricted common stock on 12/01/2025 at a price of $0 per share.

Q: When do the newly granted Electromed (ELMD) restricted shares vest?

The 3,000 restricted shares are scheduled to vest on June 1, 2026 , unless they are accelerated or terminated according to their terms.

Q: What type of transaction is reported for Electromed (ELMD) in this Form 4?

The filing reports an acquisition (A) of common stock in the form of a restricted stock grant to a director, rather than an open-market purchase or sale.

Q: Is the Electromed (ELMD) Form 4 filed by one or multiple reporting persons?

The Form 4 is indicated as being filed by one reporting person , not by a group or multiple insiders.

Q: What is the relationship of the reporting person to Electromed (ELMD)?

The reporting person is identified as a director of Electromed, Inc. and is not marked as a 10% owner in the disclosure.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Electromed, Inc. reported an insider stock award for one of its directors. On 12/01/2025, the director acquired 3,000 shares of common stock, described as restricted stock, at a price of $0 per share. After this grant, the director beneficially owns 35,622 shares of Electromed common stock.

The restricted shares are scheduled to vest on June 1, 2026, unless they are accelerated or terminated under their terms. This filing is a routine disclosure of insider equity compensation and does not involve a public offering or sale of shares into the market.

Insider Trade Summary

Net Buyer: 3,000 shares

Net Buy 1 txn

Insider SKARVAN KATHLEEN

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 35,622 shares (Direct)

Footnotes (1)

F1. Restricted Stock scheduled to vest on June 1, 2026, unless earlier accelerated or terminated pursuant to their terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 12/03/2025 - 08:10 PM

FAQ

What did Electromed (ELMD) disclose in this Form 4 filing?

Electromed (ELMD) disclosed that one of its directors received a grant of 3,000 shares of restricted common stock on 12/01/2025 at a price of $0 per share.

How many Electromed (ELMD) shares does the reporting person now own?

Following the reported transaction, the director beneficially owns 35,622 shares of Electromed, Inc. common stock.

When do the newly granted Electromed (ELMD) restricted shares vest?

The 3,000 restricted shares are scheduled to vest on June 1, 2026, unless they are accelerated or terminated according to their terms.

What type of transaction is reported for Electromed (ELMD) in this Form 4?

The filing reports an acquisition (A) of common stock in the form of a restricted stock grant to a director, rather than an open-market purchase or sale.

Is the Electromed (ELMD) Form 4 filed by one or multiple reporting persons?

The Form 4 is indicated as being filed by one reporting person, not by a group or multiple insiders.

What is the relationship of the reporting person to Electromed (ELMD)?

The reporting person is identified as a director of Electromed, Inc. and is not marked as a 10% owner in the disclosure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SKARVAN KATHLEEN

(Last)

(First)

(Middle)

500 SIXTH AVENUE NW

(Street)

NEW PRAGUE

56071

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Electromed, Inc. [ ELMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	12/01/2025		A		3,000⁽¹⁾	A	$0	35,622	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted Stock scheduled to vest on June 1, 2026, unless earlier accelerated or terminated pursuant to their terms.

	/s/ Joshua L. Colburn, Attorney-in-fact	12/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR